Integrated Proteins Limited has issued a regulatory disclosure to BSE Limited intimating a scheduled meeting of its Board of Directors.
The Board Meeting is scheduled to be held on Friday, August 14, 2026, at the company's Registered Office located at Office no. 218, Manek Centre, Pandit Nehru Marg, Patel Colony, Jamnagar, 361008, Gujarat.
The primary agenda for the meeting is:
- To Consider and Approve the unaudited Financial Results of the Company for the quarter ended on June 30, 2026.
- To review the Limited Review Report for the same period.
This agenda item is being undertaken in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
A secondary, general agenda item allows for the consideration of any other matter with the permission of the Chair and a majority of the directors.
Furthermore, the company has confirmed a closure of the trading window for insiders. In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended in 2018) and the company's internal Code of Conduct, the window was closed starting Wednesday, July 1, 2026. The trading window is stipulated to reopen 48 hours after the declaration of the financial results or the submission of the meeting's outcome.
The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The letter was digitally signed by Hiren Dhirajlal Shah, Chairman and Managing Director (DIN: 09842161).